M Novi1, C Vanni2, P D Parchi3, M Di Paolo2, N Piolanti3, M Scaglione3. 1. 1° Orthopaedic and Traumatology Unit, Department of Translational Research and New Technology in Medicine and Surgery, University Hospital of Pisa, Via Paradisa, 2, 56100, Pisa, Italy. miche.novi@gmail.com. 2. Law Medicine Unit, University Hospital of Pisa, Pisa, Italy. 3. 1° Orthopaedic and Traumatology Unit, Department of Translational Research and New Technology in Medicine and Surgery, University Hospital of Pisa, Via Paradisa, 2, 56100, Pisa, Italy.
Abstract
PURPOSE: Over the years, the number of total hip replacements has been steadily increasing. Despite the improvement in surgical results, the number of claims for malpractice is higher. The primary endpoint of this work is to provide an analysis of litigation after hip replacement, to outline what are the instigating causes and costs. The secondary endpoint is to propose a possible preventive strategy for an improved care and a reduction in legal proceedings. MATERIALS AND METHODS: The data of this study were collected from medical and legal files and from professional liability insurance of our institution from January 2005 to December 2016. RESULTS: Out of a total of 4770 THA, 40 claims were received. Peripheral nerve injuries represent the first cause of litigation (37%), followed by infectious complications, leg length discrepancy, metallosis, dislocations of the implant and a case of deep vein thrombosis. From the analysis of the past trial judgment, complications such as nerve lesions and infections are almost always recognized, as a medical error, with a high percentage of claims settled. CONCLUSION: This study shows the necessity of preventive strategies to reduce the higher number of claims for malpractice in total hip arthroplasty. Some complications such as nerve injuries and infection are frequently considered directly dependent on physician's errors. Litigations can be reduced providing evidence of a diligent execution of the surgical procedure and of a proper postoperative management: the correct compilation of a specific informed consent and adequate doctor-patient communication.
PURPOSE: Over the years, the number of total hip replacements has been steadily increasing. Despite the improvement in surgical results, the number of claims for malpractice is higher. The primary endpoint of this work is to provide an analysis of litigation after hip replacement, to outline what are the instigating causes and costs. The secondary endpoint is to propose a possible preventive strategy for an improved care and a reduction in legal proceedings. MATERIALS AND METHODS: The data of this study were collected from medical and legal files and from professional liability insurance of our institution from January 2005 to December 2016. RESULTS: Out of a total of 4770 THA, 40 claims were received. Peripheral nerve injuries represent the first cause of litigation (37%), followed by infectious complications, leg length discrepancy, metallosis, dislocations of the implant and a case of deep vein thrombosis. From the analysis of the past trial judgment, complications such as nerve lesions and infections are almost always recognized, as a medical error, with a high percentage of claims settled. CONCLUSION: This study shows the necessity of preventive strategies to reduce the higher number of claims for malpractice in total hip arthroplasty. Some complications such as nerve injuries and infection are frequently considered directly dependent on physician's errors. Litigations can be reduced providing evidence of a diligent execution of the surgical procedure and of a proper postoperative management: the correct compilation of a specific informed consent and adequate doctor-patient communication.
Entities:
Keywords:
Claim; Complication; Costs; Hip arthroplasty; Litigation
Authors: Daniel J Berry; Richard A Berger; John J Callaghan; Lawrence D Dorr; Paul J Duwelius; Mark A Hartzband; Jay R Lieberman; Dana C Mears Journal: J Bone Joint Surg Am Date: 2003-11 Impact factor: 5.284
Authors: Nicolas J Beresford-Cleary; Nicolas Beresford-Cleary; Jane Halliday; S Jane Breusch; Jane Breusch; L C Biant; Jane Biant Journal: J Orthop Surg (Hong Kong) Date: 2011-12 Impact factor: 1.118
Authors: Imme Zengerink; Max Reijman; Nina M C Mathijssen; Manon P Eikens-Jansen; P Koen Bos Journal: J Arthroplasty Date: 2016-03-09 Impact factor: 4.757
Authors: Mikko S Venäläinen; Valtteri J Panula; Riku Klén; Jaason J Haapakoski; Antti P Eskelinen; Mikko J Manninen; Jukka S Kettunen; Ari-Pekka Puhto; Anna I Vasara; Keijo T Mäkelä; Laura L Elo Journal: JB JS Open Access Date: 2021-01-25